Marjorie Dannenfelser of SBA Pro-Life America backs Hawley's bill to withdraw FDA approval of mifepristone
Marjorie DannenfelserPresident of Susan B. Anthony Pro-Life America (SBA Pro-Life America), in a statement of support released through Senator Hawley's office
Marjorie Dannenfelser, president of SBA Pro-Life America, said the Safeguarding Women from Chemical Abortion Act would address what she called a severe public health crisis by withdrawing the FDA's approval of abortion drugs. She thanked Hawley and Harshbarger for understanding the gravity of the situation and for their work to find ways Congress can act.
“At least 1.1 million children will be aborted this year in America – more than before Roe v. Wade was reversed – if the FDA won't act to stop it. The number 1 factor making abortion America’s top cause of death is mail-order abortion drugs, a dangerous relic of the Covid and Biden era that inexplicably continues to this day. This makes it impossible for states to protect women and children, creating a severe public health crisis. The Safeguarding Women from Chemical Abortion Act would address this head-on by withdrawing the politicized FDA approval of these dangerous abortion drugs. We are thankful to Senator Hawley and Congresswoman Harshbarger for understanding the gravity of this situation and for their work to find ways that Congress can step up to address it”
Official statement
Official statement
Where this statement fits
Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and let women who say chemical abortion harmed them sue its manufacturers. Mifepristone has been approved in the United States since 2000 and is used in a large majority of American abortions. Hawley argues a national ban is the only remedy because the drug can be mailed into states whose own laws restrict abortion. The bill drew seven Republican cosponsors but has not moved out of the Senate Health, Education, Labor and Pensions Committee. On September 16, 2026, Hawley unveiled a four-page "Declaration for Life" and began asking officeholders and candidates to sign it as a commitment to ban the drug. The dispute is over whether Congress should enact that ban.
Source and context
Official statement
About this source
Two-page compilation of statements of support for the bill from eight anti-abortion organizations, released by Senator Hawley's office and linked from his March 11, 2026 announcement of the bill.
Archived copy (opens in a new tab)Official statement
About this source
Hawley's own announcement of the bill, issued alongside a Capitol Hill press conference with anti-abortion movement leaders. It states the bill's three operative provisions and carries the quotation on which his safety claim rests.
Archived copy (opens in a new tab)Before the quotation
Hawley introduced the bill on March 11, 2026. His release named Susan B. Anthony Pro-Life America among eight supporting organizations and provided a link to their statements of support.
After the quotation
The same two-page document carries statements of support from seven other organizations, including the Family Research Council, Live Action and Students for Life of America.
How this statement is classified
The label describes this statement's response within the context above.
Why this label?
The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. Dannenfelser said the bill would address what she called a severe public health crisis by withdrawing the FDA's approval of abortion drugs, and thanked Hawley and Harshbarger for their work to find ways Congress can act. That is direct support for the ban, so we labeled it Defended or excused.
- Recorded on
- Published here
- People and groups discussed
- Josh Hawley
More from this case
Read the full caseGenBioPro declines to comment on Hawley's bill to ban mifepristone
GenBioPro
“At this time, the company prefers not to comment.”Read statement
Hawley urges FDA action on abortion-drug availability
“We've got to make sure that she is committed to ending the abortion drugs' availability in the state of Missouri and every other state. That they're going to put back in place the safety restrictions and they're going to follow the law.”Read statement
Tony Perkins says the Republican Party has "lost its voice" on abortion and credits Hawley with filling the vacuum
“Unfortunately the Republican Party has lost its voice on the life issue and in that vacuum there are leaders that are stepping forward like Sen. Hawley calling upon the church, communities and the country to step up on behalf of the unborn.”Read statement
Share or embed this statement
The embed keeps its attribution link to The Dispute Index. Credit the image to The Dispute Index and link to the statement page.
Cite this record
- Publisher
- The Dispute Index
- Title
- Marjorie Dannenfelser of SBA Pro-Life America backs Hawley's bill to withdraw FDA approval of mifepristone
- First published
- Last updated
- Permalink
- https://disputeindex.com/events/2783-marjorie-dannenfelser-president-of-sba-pro-life-america
Last updated marks the most recent saved version of this published statement.
The Dispute Index. "Marjorie Dannenfelser of SBA Pro-Life America backs Hawley's bill to withdraw FDA approval of mifepristone". First published: 2026-09-26. Last updated: 2026-09-26. https://disputeindex.com/events/2783-marjorie-dannenfelser-president-of-sba-pro-life-america